Process View
Any process that increases the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of cell cycle arrest"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.999 | Human | |
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.995 | ||
RB1 | retinoblastoma 1 | 0.993 | ||
XIAP | X-linked inhibitor of apoptosis | 0.956 | ||
TAL1 | T-cell acute lymphocytic leukemia 1 | 0.909 | ||
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.825 | ||
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.824 | Human | |
PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.705 | ||
TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.617 | ||
POU3F2 | POU class 3 homeobox 2 | 0.558 | ||
MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.460 | Human | |
FAS | Fas (TNF receptor superfamily, member 6) | 0.447 | ||
APAF1 | apoptotic peptidase activating factor 1 | 0.436 | ||
CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.406 | ||
PPP2R1B | protein phosphatase 2, regulatory subunit A, beta | 0.391 | ||
CCND1 | cyclin D1 | 0.373 | ||
CDK6 | cyclin-dependent kinase 6 | 0.371 | ||
TP53 | tumor protein p53 | 0.338 | ||
CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.318 | Human | |
BCL2 | B-cell CLL/lymphoma 2 | 0.299 | ||
RBL1 | retinoblastoma-like 1 (p107) | 0.283 | ||
LRDD | leucine-rich repeats and death domain containing | 0.283 | ||
SMAD7 | SMAD family member 7 | 0.280 | ||
AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.270 | ||
PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.242 | ||
PKD1 | polycystic kidney disease 1 (autosomal dominant) | 0.221 | ||
PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.190 | ||
RARA | retinoic acid receptor, alpha | 0.182 | ||
RXRA | retinoid X receptor, alpha | 0.178 | ||
CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.177 | Human | |
NLRC4 | NLR family, CARD domain containing 4 | 0.174 | ||
CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.164 | Human | |
CDK2 | cyclin-dependent kinase 2 | 0.163 | ||
E2F1 | E2F transcription factor 1 | 0.159 | ||
CASP2 | caspase 2, apoptosis-related cysteine peptidase | 0.153 | ||
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.151 | ||
UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.150 | ||
FASLG | Fas ligand (TNF superfamily, member 6) | 0.147 | ||
TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.145 | ||
CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.141 | ||
PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.133 | Human | |
WWOX | WW domain containing oxidoreductase | 0.131 | ||
RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.124 | ||
CCNE1 | cyclin E1 | 0.121 | ||
AXIN1 | axin 1 | 0.118 | ||
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | 0.110 | ||
MED1 | mediator complex subunit 1 | 0.099 | ||
DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | 0.091 | ||
DAXX | death-domain associated protein | 0.091 | ||
RBL2 | retinoblastoma-like 2 (p130) | 0.090 | ||
BIRC2 | baculoviral IAP repeat containing 2 | 0.088 | ||
RUNX1 | runt-related transcription factor 1 | 0.080 | ||
HDAC1 | histone deacetylase 1 | 0.079 | ||
SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.074 | ||
UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.072 | ||
IER3 | immediate early response 3 | 0.070 | ||
USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.070 | ||
CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.066 | Human | |
NMI | N-myc (and STAT) interactor | 0.062 | ||
RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.062 | ||
SP1 | Sp1 transcription factor | 0.061 | ||
CABLES1 | Cdk5 and Abl enzyme substrate 1 | 0.060 | ||
CCND3 | cyclin D3 | 0.058 | ||
MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.058 | ||
IFI16 | interferon, gamma-inducible protein 16 | 0.054 | ||
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.049 | ||
SATB2 | SATB homeobox 2 | 0.046 | ||
CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.045 | Human | |
MEOX2 | mesenchyme homeobox 2 | 0.043 | ||
KRT5 | keratin 5 | 0.043 | ||
PAX3 | paired box 3 | 0.042 | ||
CSNK1A1 | casein kinase 1, alpha 1 | 0.042 | ||
NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.038 | ||
ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.038 | ||
FADD | Fas (TNFRSF6)-associated via death domain | 0.036 | ||
CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.035 | Human | |
GSK3B | glycogen synthase kinase 3 beta | 0.034 | ||
TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.034 | ||
POLD1 | polymerase (DNA directed), delta 1, catalytic subunit 125kDa | 0.033 | ||
ZNF420 | zinc finger protein 420 | 0.031 | ||
SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.031 | ||
CDC25A | cell division cycle 25 homolog A (S. pombe) | 0.030 | ||
PPP2R5D | protein phosphatase 2, regulatory subunit B', delta | 0.028 | Human | |
RYR2 | ryanodine receptor 2 (cardiac) | 0.028 | ||
POU5F1 | POU class 5 homeobox 1 | 0.028 | ||
TP53BP2 | tumor protein p53 binding protein, 2 | 0.027 | ||
SPRR2A | small proline-rich protein 2A | 0.027 | ||
PML | promyelocytic leukemia | 0.027 | Mouse | |
TRPC1 | transient receptor potential cation channel, subfamily C, member 1 | 0.027 | ||
SMAD4 | SMAD family member 4 | 0.026 | ||
CDT1 | chromatin licensing and DNA replication factor 1 | 0.026 | ||
SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.025 | ||
YAP1 | Yes-associated protein 1 | 0.025 | ||
MARCKSL1 | MARCKS-like 1 | 0.025 | ||
PPFIA1 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 | 0.025 | ||
TGFBR1 | transforming growth factor, beta receptor 1 | 0.024 | ||
NUCB2 | nucleobindin 2 | 0.024 | ||
PPP2R5B | protein phosphatase 2, regulatory subunit B', beta | 0.023 | Human Rat | |
PRMT6 | protein arginine methyltransferase 6 | 0.023 | ||
SORBS3 | sorbin and SH3 domain containing 3 | 0.023 | ||
SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.022 | ||
VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.022 | ||
SIRT1 | sirtuin 1 | 0.022 | ||
IGF2BP1 | insulin-like growth factor 2 mRNA binding protein 1 | 0.022 | ||
PRKACB | protein kinase, cAMP-dependent, catalytic, beta | 0.021 | ||
TRIM43 | tripartite motif containing 43 | 0.020 | ||
ANXA7 | annexin A7 | 0.020 | ||
NOTCH1 | notch 1 | 0.019 | ||
ZFPM1 | zinc finger protein, multitype 1 | 0.019 | ||
RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.019 | ||
ENG | endoglin | 0.019 | ||
SMAD3 | SMAD family member 3 | 0.019 | ||
ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.019 | ||
SALL2 | sal-like 2 (Drosophila) | 0.019 | ||
PPP5C | protein phosphatase 5, catalytic subunit | 0.018 | ||
DOCK8 | dedicator of cytokinesis 8 | 0.018 | ||
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.018 | ||
SGK3 | serum/glucocorticoid regulated kinase family, member 3 | 0.017 | ||
FSTL1 | follistatin-like 1 | 0.017 | ||
TIAM1 | T-cell lymphoma invasion and metastasis 1 | 0.017 | ||
CTSS | cathepsin S | 0.016 | ||
ABI2 | abl-interactor 2 | 0.016 | ||
CDK5 | cyclin-dependent kinase 5 | 0.015 | ||
KIF1C | kinesin family member 1C | 0.015 | ||
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | 0.015 | ||
E2F4 | E2F transcription factor 4, p107/p130-binding | 0.015 | ||
ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.015 | ||
ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 0.014 | ||
SKP2 | S-phase kinase-associated protein 2 (p45) | 0.014 | ||
ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.014 | ||
KRT6C | keratin 6C | 0.014 | ||
SOCS1 | suppressor of cytokine signaling 1 | 0.014 | ||
BTN3A2 | butyrophilin, subfamily 3, member A2 | 0.014 | ||
SMAD5 | SMAD family member 5 | 0.014 | ||
E2F2 | E2F transcription factor 2 | 0.014 | ||
ATM | ataxia telangiectasia mutated | 0.014 | ||
ATF3 | activating transcription factor 3 | 0.013 | ||
CBFA2T3 | core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | 0.013 | ||
MSH5 | mutS homolog 5 (E. coli) | 0.013 | ||
DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.013 | ||
PPAN | peter pan homolog (Drosophila) | 0.013 | ||
SMAD2 | SMAD family member 2 | 0.013 | ||
DZIP1 | DAZ interacting protein 1 | 0.012 | ||
CDK9 | cyclin-dependent kinase 9 | 0.012 | ||
WT1 | Wilms tumor 1 | 0.012 | ||
CASP8AP2 | caspase 8 associated protein 2 | 0.012 | ||
DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.012 | ||
CARD16 | caspase recruitment domain family, member 16 | 0.012 | ||
TCF12 | transcription factor 12 | 0.012 | ||
CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0.012 | ||
HELLS | helicase, lymphoid-specific | 0.012 | ||
MTHFD1L | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like | 0.012 | ||
CCND2 | cyclin D2 | 0.012 | ||
WASF1 | WAS protein family, member 1 | 0.011 | ||
PPME1 | protein phosphatase methylesterase 1 | 0.011 | ||
CUX1 | cut-like homeobox 1 | 0.011 | ||
SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.011 | ||
ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 0.011 | Mouse | |
IL18 | interleukin 18 (interferon-gamma-inducing factor) | 0.011 | ||
ZBTB16 | zinc finger and BTB domain containing 16 | 0.011 | ||
SUV39H1 | suppressor of variegation 3-9 homolog 1 (Drosophila) | 0.011 | ||
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | 0.011 | ||
SMC1A | structural maintenance of chromosomes 1A | 0.011 | ||
MAPK7 | mitogen-activated protein kinase 7 | 0.011 | ||
STK38L | serine/threonine kinase 38 like | 0.011 | ||
MDFI | MyoD family inhibitor | 0.011 | ||
E2F3 | E2F transcription factor 3 | 0.011 | ||
SAMD4A | sterile alpha motif domain containing 4A | 0.011 | ||
GBP2 | guanylate binding protein 2, interferon-inducible | 0.011 | ||
RAI1 | retinoic acid induced 1 | 0.011 | ||
MAGED1 | melanoma antigen family D, 1 | 0.011 | ||
DTX1 | deltex homolog 1 (Drosophila) | 0.010 | ||
CAMK2A | calcium/calmodulin-dependent protein kinase II alpha | 0.010 | ||
COL2A1 | collagen, type II, alpha 1 | 0.010 | ||
EFNB3 | ephrin-B3 | 0.010 | ||
SOX9 | SRY (sex determining region Y)-box 9 | 0.010 | Human | |
PRKAR1B | protein kinase, cAMP-dependent, regulatory, type I, beta | 0.010 | ||
BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | 0.010 | ||
DYRK1B | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | 0.010 | ||
GORAB | golgin, RAB6-interacting | 0.010 |